Table 3. VTE characteristics.
| Variable, n (%) | VKA ( N = 3,043) | DOAC ( N = 4,991) |
|---|---|---|
| VTE type | ||
| DVT | 1,920 (63.1) | 2,978 (59.7) |
| PE | 740 (24.3) | 1,127 (22.6) |
| DVT and PE | 383 (12.6) | 886 (17.8) |
| Site of DVT | ||
| Upper limb | 86 (3.7) | 180 (4.7) |
| Lower limb | 2,184 (95.1) | 3,630 (93.9) |
| Caval vein (inferior) | 15 (0.7) | 32 (0.8) |
| Caval vein (superior) | 12 (0.5) | 22 (0.6) |
| Type of lower limb DVT | ||
| Distal | 638 (29.5) | 1,394 (38.8) |
| Proximal | 956 (44.2) | 1,143 (31.8) |
| Proximal & distal | 570 (26.3) | 1,057 (29.4) |
| Missing | 879 | 1,397 |
| Type of PE | ||
| Main | 308 (27.6) | 560 (28.1) |
| Lobar | 360 (32.3) | 571 (28.6) |
| Segmental | 338 (30.3) | 677 (34.0) |
| Sub-segmental | 109 (9.8) | 186 (9.3) |
| Missing | 1,928 | 2,997 |
Abbreviations: DOAC, direct oral anticoagulants; DVT, deep vein thrombosis; PE, pulmonary embolism; VKA, vitamin K antagonist; VTE, venous thromboembolism.